News & Analysis
- All News
- Analysis
- People
- Real Assets
  - M&A Deals
  - News
- Legal
Markets
Geography
- UK
- France
- DACH
- Benelux
- Nordics
  - Sweden
  - Finland
  - Norway
  - Denmark
  - Iceland
- Southern Europe
  - Italy
  - Spain
  - Portugal
  - Greece
  - Turkey
- CEE
- Other
  - Georgia
  - Ireland
  - Russia
- MENA
  - Abu Dhabi
  - Dubai
  - Egypt
  - GCC
  - Israel
  - Morocco
  - Saudi Arabia
  - UAE
Rankings & Reports
Resources & Events
About
Contact
Subscribe
Newsletter
Basket

Sign in

Welcome!Log into your account

your username

your password

Forgot your password?

Create an account

Sign up

Welcome!Register for an account

your email

your username

A password will be e-mailed to you.

Password recovery

Recover your password

your email

Search

Thursday, September 24, 2026

Sign in / Join

About
Contact
SUBSCRIBE

Sign in

Welcome! Log into your account

your username

your password

Forgot your password? Get help

Create an account

Create an account

Welcome! Register for an account

your email

your username

A password will be e-mailed to you.

Password recovery

Recover your password

your email

A password will be e-mailed to you.

Investors in Healthcare

News & Analysis
- …
  
  Subscription required
  
  This content is for Subscribers only. To access 5,700+ articles from an archive of 7 years plus data tables on M&A, Equity, Debt and more
  
  Subscribe
  
  Already have an account? Sign In
- All News
- Analysis
- People
- Real Assets
  - M&A Deals
  - News
- Legal
Markets
- Healthcare
  Clinical Labs
  
  Consumer Healthcare
  
  Cosmetic & Aesthetics
  
  Dental
  
  Diagnostics
  
  Digital Health/Healthtech
  
  Distribution
  
  Fertility
  
  Funeral Services
  
  Hospitals and Clinics
  
  Insurance
  
  Mental Health
  
  Ophthalmology
  
  Pharmacy
  
  Primary Care
  
  Staffing
  
  Education
  Children’s Residential Services
  
  Fostering
  
  Nurseries
  
  SEN Schools
  
  Life Sciences
  IVD – Reagents
  
  IVD – Tools
  
  Medtech – Diagnostics
  
  Medtech – Healthcare IT
  
  Medtech – Hospital Equipment
  
  Medtech – Medical Devices and Implants
  
  Pharma
  Manufacturing – Generics
  
  Manufacturing – OTC
  
  Manufacturing – Specialty Pharma
  
  Services – Bioinformatics
  
  Services – CRO/CMO/CDMO
  
  Services – Medical Communications
  
  Social Care
  Care Homes
  
  Complex Behavioural Care
  
  Homecare
  
  Retirement Housing
  
  Supported Living
  
  Veterinary
  Animal Health
  
  Veterinary Clinics
  Subscription required
  
  This content is for Subscribers only. To access 5,700+ articles from an archive of 7 years plus data tables on M&A, Equity, Debt and more
  
  Subscribe
  
  Already have an account? Sign In
- Healthcare
- Education
- Life Sciences
- Pharma
- Social Care
- Veterinary
  - Animal Health
  - Veterinary Clinics
Geography
- …
  
  Subscription required
  
  This content is for Subscribers only. To access 5,700+ articles from an archive of 7 years plus data tables on M&A, Equity, Debt and more
  
  Subscribe
  
  Already have an account? Sign In
- UK
- France
- DACH
- Benelux
- Nordics
  - Sweden
  - Finland
  - Norway
  - Denmark
  - Iceland
- Southern Europe
  - Italy
  - Spain
  - Portugal
  - Greece
  - Turkey
- CEE
- Other
  - Georgia
  - Ireland
  - Russia
- MENA
  - Abu Dhabi
  - Dubai
  - Egypt
  - GCC
  - Israel
  - Morocco
  - Saudi Arabia
  - UAE
Rankings & Reports
Resources & Events
About
Contact
Subscribe
Newsletter
Basket

Advertisement

Home Tags AbolerIS Pharma

Tag: AbolerIS Pharma

Financing round-up: AWAK Technologies, Canton Biologics, AbolerIS Pharma, EverImmune

Nick Herbert - 20th September 2023

Advertisement

Our Partners

📰 Find us on Google News

Site Map

Markets
Healthcare
Education
Life Sciences
Pharma
Social Care
Veterinary

News & Analysis
All News
In-Depth Analysis
People
Real Assets
Legal

Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report

Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference

Company
About
Contact Us
Subscribe
Newsletter
EHIA

Get in touch

Investors in Healthcare
11-13 Cavendish Square
London
W1G 0AN
UK

what3words: ///deny.budget.wiser

+44 20 7173 0548

© 2026 Investors in Healthcare Ltd. All rights reserved.